2008;52:1693 701. 412. Held C, Asenblad N, Bassand JP, et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery: results from the PLATO (Platelet Inhibition and Patient Outcomes) trial. J Am Coll Cardiol. 2011;57:672 84. 413. Hongo RH, Ley J, Dick SE, et al. The effect of clopidogrel in combina- tion with aspirin when given before coronary artery bypass grafting. J Am Coll Cardiol. 2002;40:231 7. 414. Prasugrel [Label]. Indianapolis, IN: Eli Lilly and Co, 2009. 415. Firanescu CE, Martens EJ, Schonberger JP, et al. Postoperative blood loss in patients undergoing coronary artery bypass surgery after preop- erative treatment with clopidogrel. A prospective randomised controlled study. Eur J Cardiothorac Surg. 2009;36:856 62. 416. Herman CR, Buth KJ, Kent BA, et al. Clopidogrel increases blood trans- fusion and hemorrhagic complications in patients undergoing cardiac surgery. Ann Thorac Surg. 2010;89:397 402. 417. Mehta RH, Sheng S, O Brien SM, et al. Reoperation for bleeding in patients undergoing coronary artery bypass surgery: incidence, risk factors, time trends, and outcomes. Circ Cardiovasc Qual Outcomes. 2009;2:583 90. 418. Bizzarri F, Scolletta S, Tucci E, et al. Perioperative use of tirofiban hydro- chloride (Aggrastat) does not increase surgical bleeding after emergency or urgent coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2001;122:1181 5. 419. Dyke CM, Bhatia D, Lorenz TJ, et al. Immediate coronary artery bypass surgery after platelet inhibition with eptifibatide: results from PURSUIT. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrelin Therapy. Ann Thorac Surg. 2000;70:866 71. 420. Levine GN, Lincoff AM, Ferguson JJ III, et al. Utilization of catheter- ization and revascularization procedures in patients with non-ST seg- ment elevation acute coronary syndrome over the last decade. Catheter Cardiovasc Interv. 2005;66:149 57. 421. Parikh SV, de Lemos JA, Jessen ME, et al. 